Eyeworld Supplements

EW MAR 2016 - Supported by an unrestricted educational grant from Abbott Medical Optics

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/645003

Contents of this Issue

Navigation

Page 0 of 7

Supported by an unrestricted educational grant from Abbott Medical Optics Supplement to EyeWorld March 2016 Achieving premium outcomes and practice success with next-generation laser vision correction ablations by John Vukich, MD ASCRS Clinical Survey reveals laser vision correction clinical practices and looks to the future T wenty percent of ASCRS members who perform laser vision correction (LVC) do not have a standardized method to assess successful outcomes, according to results of the 2015 ASCRS Clinical Survey (Figure 1). When assess- ing successful outcomes, 43% consider patient satisfaction and 65% consider a visual acuity of 20/20 or better a success- ful outcome. In today's clinical environment, however, 20/20 vision is only part of the equation. Patients have higher expecta- tions that have to be met for them to feel satisfied with their outcome. Survey objectives Compiling responses from more than 2,000 unique respondents, the 2015 ASCRS Clinical Survey was conducted to learn more about members' clinical opinions and practice patterns, drawing 485 data points from 174 questions. This annual survey examines the current state of affairs and directs future ASCRS educa- tion efforts. When respondents were asked which ablation type accounted for the majority of their corneal refractive proce- dures, 52% responded wavefront-guided ablation, but only 44% reported that it will account for most of their corneal refractive procedures in 2 to 3 years. This change probably results from respon- dents' installed base of equipment and competition from other platforms. Figure 1. ASCRS members indicated how they assess successful LVC outcomes in the 2015 Clinical Survey. % All We don't have a standardized way of assessing outcomes 20% Uncorrected visual acuity – we look at the percent of patients with 20/20 or better UCVA 65% Uncorrected visual acuity – we look at the percent of patients with 20/16 or better UCVA 17% Ratio of patients with postop UCVA > preop BCVA 15% Patient satisfaction ratings 43% Visual quality contrast sensitivity testing 9% • How are you currently assessing successful laser vision correction surgery outcomes in your practice? (Select all that apply) • 20% of respondents don't have a standardized way of assessing outcomes • 65% use UCVA of 20/20 or better Figure 2. Survey respondents shared their expectations regarding future growth or decline of laser vision correction procedures in their practice within the next 12 months. • What percentage growth or decline do you think will occur in your annual laser vision correction procedure volumes in the next 12 months? • 37% think there will be more than 10% growth No growth or decline 1 to 10% growth >10% growth 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% All U.S. Non U.S. continued on page 3

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - EW MAR 2016 - Supported by an unrestricted educational grant from Abbott Medical Optics